BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ibarra LE, Camorani S, Agnello L, Pedone E, Pirone L, Chesta CA, Palacios RE, Fedele M, Cerchia L. Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles. Pharmaceutics 2022;14:626. [DOI: 10.3390/pharmaceutics14030626] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Yi M, Xiong B, Li Y, Guo W, Huang Y, Lu B. Manipulate tumor hypoxia for improved photodynamic therapy using nanomaterials. Eur J Med Chem 2023;247:115084. [PMID: 36599230 DOI: 10.1016/j.ejmech.2022.115084] [Reference Citation Analysis]
2 Shi Y, Zhao Y, Kang W, Lu W, Chen D, Tao J, Li J, Yu R, Zhao J, Tang R, Teng Z, Weng L. Flexible Hollow Human Serum Albumin-Catalase Nanocapsules with High Accumulation and Uptake Ability for Enhanced Photodynamic Therapy. Int J Nanomedicine 2023;18:527-39. [PMID: 36742990 DOI: 10.2147/IJN.S393194] [Reference Citation Analysis]
3 Chen Q, Huang X, Zhang G, Li J, Liu Y, Yan X. Novel targeted pH-responsive drug delivery systems based on PEGMA-modified bimetallic Prussian blue analogs for breast cancer chemotherapy. RSC Adv 2023;13:1684-700. [PMID: 36712642 DOI: 10.1039/d2ra06631a] [Reference Citation Analysis]
4 Kong X, Qi Y, Wang X, Jiang R, Wang J, Fang Y, Gao J, Chu Hwang K. Nanoparticle Drug Delivery Systems and Their Applications as Targeted Therapies for Triple Negative Breast Cancer. Progress in Materials Science 2023. [DOI: 10.1016/j.pmatsci.2023.101070] [Reference Citation Analysis]
5 Razlansari M, Jafarinejad S, rahdar A, Shirvaliloo M, Arshad R, Fathi-karkan S, Mirinejad S, Sargazi S, Sheervalilou R, Ajalli N, Pandey S. Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer. Mol Cell Biochem 2022. [DOI: 10.1007/s11010-022-04614-x] [Reference Citation Analysis]
6 Gholikhani T, Kumar S, Valizadeh H, Mahdinloo S, Adibkia K, Zakeri-Milani P, Barzegar-Jalali M, Jimenez B. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics. Int J Mol Sci 2022;23. [PMID: 36430951 DOI: 10.3390/ijms232214475] [Reference Citation Analysis]
7 Huang K, Yan M, Zhang H, Xue J, Chen J. A phthalocyanine-based photosensitizer for effectively combating triple negative breast cancer with enhanced photodynamic anticancer activity and immune response. Eur J Med Chem 2022;241:114644. [PMID: 35939997 DOI: 10.1016/j.ejmech.2022.114644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Camorani S, Tortorella S, Agnello L, Spanu C, d’Argenio A, Nilo R, Zannetti A, Locatelli E, Fedele M, Comes Franchini M, Cerchia L. Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells. Pharmaceutics 2022;14:2225. [DOI: 10.3390/pharmaceutics14102225] [Reference Citation Analysis]
9 Camorani S, d'Argenio A, Agnello L, Nilo R, Zannetti A, Ibarra LE, Fedele M, Cerchia L. Optimization of Short RNA Aptamers for TNBC Cell Targeting. Int J Mol Sci 2022;23:3511. [PMID: 35408872 DOI: 10.3390/ijms23073511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Spanu C, Camorani S, Tortorella S, Agnello L, Maturi M, Comes Franchini M, Cerchia L, Locatelli E. Synthesis and functionalization of casein nanoparticles with aptamers for triple-negative breast cancer targeting. New J Chem 2022. [DOI: 10.1039/d2nj03367d] [Reference Citation Analysis]